Surface Oncology Probability of Future Stock Price Finishing Over 0.96
| SURFDelisted Stock | USD 0.96 0.03 3.23% |
Surface |
Surface Oncology Target Price Odds to finish over 0.96
The tendency of Surface Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.96 | 90 days | 0.96 | about 8.31 |
Based on a normal probability distribution, the odds of Surface Oncology to move above the current price in 90 days from now is about 8.31 (This Surface Oncology probability density function shows the probability of Surface Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Surface Oncology has a beta of 0.35. This usually implies as returns on the market go up, Surface Oncology average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Surface Oncology will be expected to be much smaller as well. Additionally Surface Oncology has an alpha of 0.5886, implying that it can generate a 0.59 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Surface Oncology Price Density |
| Price |
Predictive Modules for Surface Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Surface Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Surface Oncology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Surface Oncology is not an exception. The market had few large corrections towards the Surface Oncology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Surface Oncology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Surface Oncology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.59 | |
β | Beta against Dow Jones | 0.35 | |
σ | Overall volatility | 0.13 | |
Ir | Information ratio | 0.12 |
Surface Oncology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Surface Oncology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Surface Oncology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Surface Oncology is not yet fully synchronised with the market data | |
| Surface Oncology has some characteristics of a very speculative penny stock | |
| Surface Oncology has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 30 M. Net Loss for the year was (63.59 M) with loss before overhead, payroll, taxes, and interest of (37 M). | |
| Surface Oncology currently holds about 156.65 M in cash with (59.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Surface Oncology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Surface Stock often depends not only on the future outlook of the current and potential Surface Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Surface Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 55.8 M | |
| Cash And Short Term Investments | 124.8 M |
Surface Oncology Technical Analysis
Surface Oncology's future price can be derived by breaking down and analyzing its technical indicators over time. Surface Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Surface Oncology. In general, you should focus on analyzing Surface Stock price patterns and their correlations with different microeconomic environments and drivers.
Surface Oncology Predictive Forecast Models
Surface Oncology's time-series forecasting models is one of many Surface Oncology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Surface Oncology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Surface Oncology
Checking the ongoing alerts about Surface Oncology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Surface Oncology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Surface Oncology is not yet fully synchronised with the market data | |
| Surface Oncology has some characteristics of a very speculative penny stock | |
| Surface Oncology has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 30 M. Net Loss for the year was (63.59 M) with loss before overhead, payroll, taxes, and interest of (37 M). | |
| Surface Oncology currently holds about 156.65 M in cash with (59.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Surface Stock
If you are still planning to invest in Surface Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surface Oncology's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |